PPFIA4 and cancer: The high expression of PPFIA4 was associated with reduced drug sensitivity of cancer cells to one drug (Dexrazoxane) and with increased drug sensitivity of cancer cells to three drugs (Idelalisib, Abiraterone, and IPI-145).